Capital Partners Llc Aisling is 10% at Esperion Therapeutics, Inc. (ESPR). They have made 1 open-market trade across 1 company since 2015, most recently 2015-04-24.
CIK 0001376171
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ESPR | 1,898,851 | $6.1M |
Shares reported on the most recent Form 4, priced at the 2015-04-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ESPR | SELL | 2015-04-23 | 2015-04-27 | $108.22 | $23.5M | -35.3% | -0.8% | -0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.